Style | Citing Format |
---|---|
MLA | Monfared YK, et al.. "Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes." Applied Biochemistry and Biotechnology, vol. 191, no. 2, 2020, pp. 623-630. |
APA | Monfared YK, Honardoost M, Sarookhani MR, Farzam SA (2020). Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes. Applied Biochemistry and Biotechnology, 191(2), 623-630. |
Chicago | Monfared YK, Honardoost M, Sarookhani MR, Farzam SA. "Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes." Applied Biochemistry and Biotechnology 191, no. 2 (2020): 623-630. |
Harvard | Monfared YK et al. (2020) 'Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes', Applied Biochemistry and Biotechnology, 191(2), pp. 623-630. |
Vancouver | Monfared YK, Honardoost M, Sarookhani MR, Farzam SA. Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes. Applied Biochemistry and Biotechnology. 2020;191(2):623-630. |
BibTex | @article{ author = {Monfared YK and Honardoost M and Sarookhani MR and Farzam SA}, title = {Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes}, journal = {Applied Biochemistry and Biotechnology}, volume = {191}, number = {2}, pages = {623-630}, year = {2020} } |
RIS | TY - JOUR AU - Monfared YK AU - Honardoost M AU - Sarookhani MR AU - Farzam SA TI - Circulating Mir-135 May Serve As a Novel Co-Biomarker of Hba1c in Type 2 Diabetes JO - Applied Biochemistry and Biotechnology VL - 191 IS - 2 SP - 623 EP - 630 PY - 2020 ER - |